Fig. 3From: Efficacy and potential use of novel sustained release fillers as intracanal medicaments against Enterococcus faecalis biofilm in vitroPercentages of biofilm viability in presence of SRF-CPC and SRF-Placebo. Data expressed as mean with standard deviation. *P < 0.05, compared with SRF-Placebo and control sample; n = 6Back to article page